Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus

Pohl, 2005, The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence, JNCI, 97, 142, 10.1093/jnci/dji024

van Blankenstein, 2005, The incidence of adenocarcinoma and squamous cell carcinoma of the esophagus: Barrett's esophagus makes a difference, Am J Gastro, 100, 766, 10.1111/j.1572-0241.2005.40790.x

Sharma, 2004, A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago workshop, Gastroenterology, 127, 310, 10.1053/j.gastro.2004.04.010

Haggitt, 1978, Adenocarcinoma complicating columnar epithelium lined (Barrett's) esophagus, AJCP, 70, 1

Skinner, 1983, Barrett's esophagus: comparison of benign and malignant cases, Ann Surg, 198, 554, 10.1097/00000658-198310000-00016

Smith, 1984, The spectrum of carcinoma arising in Barrett's esophagus, Am J Burg Pathol, 8, 563, 10.1097/00000478-198408000-00001

Rosenberg, 1985, Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system, Cancer, 55, 1353, 10.1002/1097-0142(19850315)55:6<1353::AID-CNCR2820550632>3.0.CO;2-D

Paraf, 1995, Surgical pathology of adenocarcinoma arising in Barrett's esophagus, Am J Surg Pathol, 19, 183, 10.1097/00000478-199502000-00007

Cameron, 1995, Adenocarcinoma of the esophagogastric junction in Barrett's esophagus, Gastroenterology, 109, 1541, 10.1016/0016-5085(95)90642-8

Clark, 1994, Is Barrett's metaplasia the source of adenocarcinomas of the cardia?, Arch Surg., 129, 609, 10.1001/archsurg.1994.01420300051007

MacDonald, 1987, Adenocarcinoma of the esophagus and/or gastric cardia, Cancer, 1094, 10.1002/1097-0142(19870901)60:5<1094::AID-CNCR2820600529>3.0.CO;2-4

Brown, 2002, Epidemiologic trends in esophageal and gastric cancer in the United States, Surg Oncol Clin N Am, 11, 235, 10.1016/S1055-3207(02)00002-9

Theisen, 2002, Preoperative chemotherapy unmasks underlying Barrett's mucosa in patients with adenocarcinoma of the distal esophagus, Surg Endosc, 671, 10.1007/s00464-001-8307-3

Hanna, 2006, Detection of Barrett's esophagus after endoscopic healing for erosive esophagitis, Am J Gastro, 101, 1416, 10.1111/j.1572-0241.2006.00631.x

15. Society BG . Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus. http://www.bsg.org.uk. In: Gastroenterology BSo, ed; 2005.

Oberg, 2001, Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery, Ann Surg, 234, 619, 10.1097/00000658-200111000-00006

Jones, 2002, Yield of intestinal metaplasia in patients with suspected short-segment Barrett's esophagus (SSBE) on repeat endoscopy, Dig Dis Sci, 47, 108, 10.1023/A:1019697501650

Harrison, 2007, Detection of intestinal metaplasia in Barrett's esophagus: an observational comparator study suggests the need for a minimum of eight biopsies, Am J Gastro, 102, 1154, 10.1111/j.1572-0241.2007.01230.x

Shaheen, 2005, Effect of a new diagnosis of Barrett's esophagus on insurance status, Am J Gastro, 100, 577, 10.1111/j.1572-0241.2005.41422.x

Sharma, 2006, The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria, Gastroenterology, 131, 1392, 10.1053/j.gastro.2006.08.032

Eloubeide, 2001, Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease, J Clin Gastroenterol, 33, 306, 10.1097/00004836-200110000-00010

Gerson, 2001, Use of a simple symptom questionnaire to predict Barrett's esophagus in patients with symptoms of gastroesophageal reflux, Am J Gastroenterol, 96, 2005, 10.1111/j.1572-0241.2001.03933.x

Conio, 2002, Risk factors for Barrett's esophagus: a case-control study, Int J Cancer, 97, 225, 10.1002/ijc.1583

El-Serag, 2005, Abdominal obesity and the risk of Barrett's esophagus, Am J Gastro, 100, 2151, 10.1111/j.1572-0241.2005.00251.x

Sharma, 2006, Accuracy of wireless capsule endoscopy for the detection of Barrett's esophagus, Gastroenterology., 130, A262

Lin, 2007, Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux, Gastrointest Endosc, 65, 577, 10.1016/j.gie.2006.06.035

Ronkainen, 2005, Prevalence of Barrett's esophagus in the general population: an endoscopic study, Gastroenterology, 129, 1825, 10.1053/j.gastro.2005.08.053

Corley, 2002, Surveillance and survival in Barrett's adenocarcinomas: a population-based study, Gastroenterology, 122, 633, 10.1053/gast.2002.31879

Cooper, 2003, Endoscopic screening and surveillance for Barrett's esophagus: Can claims data determine its effectiveness?, Gastrointest Endosc., 57, 914, 10.1016/S0016-5107(03)70029-7

Falk, 2000, Practice patterns for surveillance of Barrett's esophagus in the United States, Gastrointest Endosc, 52, 197, 10.1067/mge.2000.107728

Gross, 1999, Management of Barrett's esophagus: a national study of practice patterns and their cost implications, Am J Gastroenterol, 94, 3440, 10.1111/j.1572-0241.1999.01606.x

Eloubeide, 2003, Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: A glimmer of hope?, Am J Gastroenterol., 98, 1627, 10.1111/j.1572-0241.2003.07454.x

Sharma, 2006, Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus, Clin Gastroenterol and Hepatol, 4, 566, 10.1016/j.cgh.2006.03.001

Montgomery, 2001, Reproducibility of the diagnosis of dysplasia in Barrett's esophagus: a reaffirmation, Hum Pathol, 32, 368, 10.1053/hupa.2001.23510

Skacel, 2000, The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression, Am J Gastroenterol, 95, 3383, 10.1111/j.1572-0241.2000.03348.x

Reid, 2000, Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia, Am J Gastroenterol, 95, 3089, 10.1111/j.1572-0241.2000.03182.x

Buttar, 2001, Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma, Gastroenterology, 120, 1630, 10.1053/gast.2001.25111

Nigro, 1999, Occult esophageal adenocarcinoma. Extent of disease and implications for effective therapy, Ann Surg, 230, 433, 10.1097/00000658-199909000-00015

Levine, 1991, Endoscopic biopsy technique for acquiring larger mucosal samples, Gastroenterologist, 37, 332

Falk, 2004, Fluorescence in situ hybridization of cytologic specimens from Barrett's esophagus: a pilot feasibility study, Gastrointest Endosc, 60, 280, 10.1016/S0016-5107(04)01687-6

Brankley, 2006, The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus, JMD, 8, 260

Sampliner, 1996, Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: preliminary results, Gastrointest Endosc, 44, 532, 10.1016/S0016-5107(96)70004-4

Overholt, 2005, Photodynamic therapy (PDT) with porfimer sodium for the ablation of high-grade dysplasia in Barrett's esophagus (BE): international, partially blinded randomized phase III trial, Gastrointest Endosc, 62, 488, 10.1016/j.gie.2005.06.047

Berenson, 1993, Restoration of squamous mucosa after ablation of Barrett's esophagus epithelium, Gastroenterology, 104, 1686, 10.1016/0016-5085(93)90646-T

Dulai, 2005, Randomized trial of argon plasma coagulation versus multipolar electrocoagulation for ablation of Barrett's esophagus, Gastrointest Endosc, 61, 232, 10.1016/S0016-5107(04)02576-3

Sharma, 2007, Balloon-based, circumferentiao, endoscopic ablation of Barrett's esophagus: 1-year follow-up of 100 patients, Gastrointest Endosc, 65, 185, 10.1016/j.gie.2006.09.033

Byrne, 1998, Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation, Am J Gastroenterol, 93, 1810, 10.1111/j.1572-0241.1998.525_b.x

Pech, 2005, Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia, Gastrointest Endosc, 62, 24, 10.1016/S0016-5107(05)00333-0

Hage, 2004, 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial, Gut, 53, 785, 10.1136/gut.2003.028860

Sharma, 2006, A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results, Gut, 44, 1233, 10.1136/gut.2005.086777

Johnston, 2005, Cryoablation of Barrett's esophagus: a pilot study, Gastrointest Endosc, 62, 842, 10.1016/j.gie.2005.05.008

Tseng, 2003, Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome - an update, J Gastrointest Surg, 7, 164, 10.1016/S1091-255X(02)00153-1

Oh, 2006, Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus, J Am Coll Surg, 203, 152, 10.1016/j.jamcollsurg.2006.05.006

Schnell, 2001, Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia, Gastroenterology, 120, 1607, 10.1053/gast.2001.25065

Nguyen, 2000, Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia, Surgery, 127, 284, 10.1067/msy.2000.103489

Luketich, 2004, Minimally invasive resection and mechanical cervical esophagogastric anastomotic techniques in the management of esophageal cancer, J Gastrointest Surg., 2004, 10.1016/j.gassur.2004.09.051

Banki, 2002, Vagal-sparing esophagectomy: a more physiologic alternative, Ann Surg, 236, 324, 10.1097/00000658-200209000-00009

Maish, 2004, Endoscopic mucosal resection as a staging technique to determine the depth of invasion of esophageal adenocarcinoma, Ann Thorac Surg, 78, 1777, 10.1016/j.athoracsur.2004.04.064

Prasad, 2007, Long term survival following endoscopic and surgical treatment of high grade dysplasia in Barrett's esophagus, Gastroenterology, 132, 1226, 10.1053/j.gastro.2007.02.017

Goda, 2007, Usefulness of magnifying endoscopy with narrow band imaging for the detection of specialized intestinal metaplasia in columnar lined esophagus, Gastrointest Endosc, 65, 36, 10.1016/j.gie.2006.03.938

Anagnostopoulos, 2007, Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging, Aliment Pharmacol Therap, 26, 501, 10.1111/j.1365-2036.2007.03374.x

Ross, 2007, Narrow band imaging directed EMR for Barrett's esophagus with high grade dysplasia, Gastrointest Endosc, 65, 166, 10.1016/j.gie.2006.06.027

Sharma, 2006, The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus, Gastrointest Endosc, 64, 167, 10.1016/j.gie.2005.10.044

Kara, 2006, Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus, Gastrointest Endosc, 64, 176, 10.1016/j.gie.2005.11.050

Canto, 2000, Methylene blue directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett's esophagus, Gastrointest Endosc, 51, 560, 10.1016/S0016-5107(00)70290-2

Ragunath, 2003, A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus, Endoscopy, 35, 998, 10.1055/s-2003-44599

Lim, 2006, Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus, Gastrointest Endosc, 64, 195, 10.1016/j.gie.2005.07.025

Horwhat, 2007, A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patienst with long-segment Barrett's esophagus, Am J Gastroenterol, 102

Guelrud, 2001, Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's Esophagus, Gastrointest Endosc, 53, 559, 10.1067/mge.2001.114059

Kiesslich, 2006, In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy, Clin Gastroenterol and Hepatol, 4, 979, 10.1016/j.cgh.2006.05.010

Evans, 2007, Identifying intestinal metaplasia at the squamocolumnar junction by using optical coherence tomography, Gastrointest Endosc, 65, 50, 10.1016/j.gie.2006.04.027

Georgakoudi, 2001, Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus, Gastroenterology, 120, 1620, 10.1053/gast.2001.24842

Rabinovitch, 2001, Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables, Am J Gastroenterol, 96, 3071, 10.1111/j.1572-0241.2001.05261.x

Reid, 2001, Predictors of progression in Barrett's esophagus II: Baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression, Am J Gastroenterol, 96, 2839, 10.1111/j.1572-0241.2001.04236.x

Sato, 2005, CpG island hypermethylation in progression of esophageal and gastric cancer, Cancer, 106, 483, 10.1002/cncr.21657

Corley, 2003, Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis, Gastroenterology, 124, 47, 10.1053/gast.2003.50008

Vaughan, 2005, Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study, Lancet Oncol, 6, 945, 10.1016/S1470-2045(05)70431-9

Heath, 2007, Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial, J Natl Cancer Inst, 99, 545, 10.1093/jnci/djk112

Buttar, 2002, Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus, Gastroenterology, 122, 1101, 10.1053/gast.2002.32371

Jankowski, 2006, Improving surveillance for Barrett's oesophagus, BMJ., 322, 1512

El-Serag, 2004, Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus, Am J Gastroenterol, 99, 1877, 10.1111/j.1572-0241.2004.30228.x

Hillman, 2004, Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus, Med J Aust, 180, 387, 10.5694/j.1326-5377.2004.tb05991.x

Ouatu-Lascar, 1999, Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression, Gastroenterology, 117, 327, 10.1053/gast.1999.0029900327

Hofstetter, 2001, Long-term outcome of antireflux surgery in patients with Barrett's esophagus, Ann Surg., 234, 532, 10.1097/00000658-200110000-00012

Csendes, 2004, Adenocarcinoma appearing very late after antireflux surgery for Barrett's esophagus: long term follow up, review of the literature, and addition of six patients, J Gastrointest Surg, 8, 434, 10.1016/j.gassur.2003.12.003

Streitz, 1993, Endoscopic surveillance of Barrett's esophagus: does it help?, J Thorac Cardiovasc Surg., 105, 383, 10.1016/S0022-5223(19)34219-9

Peters, 1994, Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients, J Thorac Cardiovasc Surg, 108, 813, 10.1016/S0022-5223(94)70178-4

vanSandick, 1998, Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma, Gut, 43, 216, 10.1136/gut.43.2.216

Incarbone, 2002, Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus, Surg Endosc, 16, 263, 10.1007/s00464-001-8161-3

Ferguson, 2002, Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients, J Gastrointest Surg, 6, 29, 10.1016/S1091-255X(01)00052-X

Fountoulakis, 2004, Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer, Br J Surg, 91, 997, 10.1002/bjs.4591